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VOL. XXXV NO. 5 THE JOURNAL OF ANTIBIOTICS maximum antibiotic production occurred after 24 hours of fermentation in spite of the fact that the growth of the producing organism (measured as volume of packed mycelium in a centrifuge tube) was only about one fourth of the maximum growth observed 72 hours of fermentation.
Isolation
The fermentation broth was filtered with the aid of diatomaceous earth at harvest pH (7.4). The filtrate was acidified with 6 N H2SO4 to pH 4.5 and was extracted twice with half volume of methylene chloride. The combined extracts were washed with water and evaporated to dryness in a rotary flash evaporator, yielding 710 mg of solid residue/10 liters of the filtered medium. A 250 mg portion of the material was chromatographed over a column (25 x 2.5 cm) of silica gel buffered to pH 5.8 with KH2PO4, using chloroform -methanol (94: 6, v/v) mixture as solvent. The active fractions were combined and evaporated to dryness. The yield was 90 mg. Three grams of similarly prepared material were further purified by a 300 transfer counter current distribution (100 nil phase) in the system afforded by ethyl acetate -ethanol -cyclohexane -water (2: 3: 3 : 2, v/v). 
Physical Characteristics and Structural Considerations
The antibiotic U-62162 exhibited absorption at 235 nm (s 14000) with an inflexion at 276 nm (s 8150) in its ultraviolet spectrum, suggestive of an a,r unsaturated ketone or aldehyde. The infrared spectrum supported this with characteristic bands at 1685 cm-1 and 1638 cm-1 (Fig. 1) . The additional absorptions observed in the carbonyl region were eventually ascribed to a carboxylic acid (1702 cm-1), and a secondary amide (1650 cm-1 and 1518 cm-1). Analytical and mass spectral considerations indicated a molecular formula of C23H33NO6, and the extraction characteristics suggested that the antibiotic U-62162 was an acid.
When this information was combined with the 13C NMR and 1H NMR data (Table 1) , the structure shown in Fig. 2 was assigned to the antibiotic U-62162. This places the antibiotic U-62162 in the family THE JOURNAL OF ANTIBIOTICS character of C-1'. With additional decoupling studies the remaining 4 methylene groups were found to be in a single chain, linked on both ends to quaternary carbons. One of these (C-11) was a carbonyl by virtue of the downfield position of the C-10 triplet (2.28 ppm) in the 1H NMR spectrum.
When proton spectra were run in Me2SO-d,, the signals for 3 additional protons were seen, all exchangeable with D2O. These included a broad peak at 12.1 ppm for COOH, a broad singlet at 9.04 ppm (NH), and a signal at 5.74 ppm which was assigned with the remaining heteroatom for OH. The carboxylic acid group could be immediately assigned to C-11.
The stoichiometry required that the remaining unassigned atoms were associated with a single moiety, C6H3O2(NH)(OH). was assigned unequivocably to C-6 by specific decoupling was also coupled long range to C-1 (JC-H=4.0 Hz). In addition to the large 1-bond couplings already described for the epoxide carbons, C-5 showed additional long range couplings (3-bond) in the gated spectrum to both the vinyl proton at C-3 and the methylenic protons on C-7, confirming its linkage to the quaternary carbon (70.56 ppm). The gated spectrum of C-6 showed a clean doublet with no 2 or 3-bond coupling. Since this antibiotic was found to be particularly active in inhibiting the growth of S. aureus, it was evaluated in vivo in mice experimentally infected with S. aureus. The maximum tolerated dose in healthy animals was 12.5 mg/kg/day when administered intraperitoneally. The highest dose tested in infected animals in the standard CD50 test was 8 mg/kg/day and at this level no protection of the animals was detected.
